申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2017023631A1
公开(公告)日:2017-02-09
The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
本公开涉及抗病毒化合物,更具体地涉及可以抑制由丙型肝炎病毒(HCV)编码的NS5A蛋白功能的化合物组合,包括这种组合的组成物,以及抑制NS5A蛋白功能的方法。